Literature DB >> 13052710

Studies on a proteolytic enzyme in human plasma. IX. Fibrinogen and fibrin as substrates for the proteolytic enzyme of plasma.

O D RATNOFF.   

Abstract

Entities:  

Keywords:  BLOOD; FIBRIN; FIBRINOGEN; FIBRINOLYSIN; STREPTODORNASE AND/effects

Mesh：

Substances：

Year:  1953        PMID： 13052710      PMCID： PMC438368          DOI： 10.1172/JCI102762

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE.

Authors:  L R Christensen
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

2.  THE CLOTTING BEHAVIOR OF HUMAN "PLATELET-FREE" PLASMA: EVIDENCE FOR THE EXISTENCE OF A "PLASMA THROMBOPLASTIN".

Authors:  C L Conley; R C Hartmann; W I Morse
Journal:  J Clin Invest       Date:  1949-03       Impact factor: 14.808

3.  Fibrinolysis induced by brain extracts.

Authors:  P FANTL; M FITZPATRICK
Journal:  Br J Exp Pathol       Date:  1950-04

4.  The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase).

Authors:  A J JOHNSON; W S TILLETT
Journal:  J Exp Med       Date:  1952-05-01       Impact factor: 14.307

5.  Studies on a proteolytic enzyme in human plasma. VIII. The effect of calcium and strontium ions on the activation of the plasma proteolytic enzyme.

Authors:  O D RATNOFF
Journal:  J Exp Med       Date:  1952-05       Impact factor: 14.307
  5 in total
  15 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  THROMBOLYTIC THERAPY.

Authors:  A S DOUGLAS; G P MCNICOL
Journal:  Proc R Soc Med       Date:  1964-07

3.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. II. Isolation and properties of the permeability factor and its inhibitor.

Authors:  D L WILHELM; A A MILES; M E MACKAY
Journal:  Br J Exp Pathol       Date:  1955-02

4.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

5.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

6.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

7.  [Blood-coagulation physiology and blood protein studies in normal menstruation and pathological uterine hemorrhages].

Authors:  F K BELLER; H GRAF
Journal:  Arch Gynakol       Date:  1957

8.  The enzymatic dissolution of experimental arterial thrombi in the dog by trypsin, chymotrypsin and plasminogen activators.

Authors:  S SHERRY; A TITCHENER; L GOTTESMAN; P WASSERMAN; W TROLL
Journal:  J Clin Invest       Date:  1954-10       Impact factor: 14.808

9.  The fibrinolytic activity of streptokinase activated human plasmin.

Authors:  S SHERRY
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

10.  Symposium on Fibrinolysis.

Authors:  J L Stafford
Journal:  Proc R Soc Med       Date:  1963-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.